# reload+after+2024-01-22 20:47:48.237209
address1§1895 Mount Hope Avenue
city§Rochester
state§NY
zip§14620
country§United States
phone§585 271 2700
fax§585 271 2765
website§https://www.vaccinex.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.
fullTimeEmployees§38
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Maurice  Zauderer Ph.D.', 'age': 77, 'title': 'Co-Founder, CEO, President & Director', 'yearBorn': 1946, 'fiscalYear': 2022, 'totalPay': 400700, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Elizabeth E. Evans Ph.D.', 'age': 51, 'title': 'COO and Senior VP of Discovery & Translational Medicine', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 255455, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ernest S. Smith Ph.D.', 'age': 51, 'title': 'Senior VP of Research & Chief Scientific Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 284021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Scott E. Royer C.F.A., M.B.A.', 'age': 49, 'title': 'Chief Financial Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 242151, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. John E. Leonard Ph.D.', 'age': 76, 'title': 'Senior Vice President of Development', 'yearBorn': 1947, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.873
priceToSalesTrailing12Months§11.299875
currency§USD
dateShortInterest§1702598400
forwardEps§-0.14
exchange§NCM
quoteType§EQUITY
shortName§Vaccinex, Inc.
longName§Vaccinex, Inc.
firstTradeDateEpochUtc§1533821400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§85e0d108-d5e4-34e8-828a-44192c187037
gmtOffSetMilliseconds§-18000000
recommendationMean§1.0
recommendationKey§strong_buy
quickRatio§0.167
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
